Skip to main content
Stonvex
Loading…
Home
Markets
Screener
Portfolio
Community
Stonvex publishes market data and research only.
Not investment advice. Not a registered investment advisor.
Read disclaimer
.
Stonvex
Search...
Cmd K
Search...
Cmd K
← Back to rankings
NPCE
Live
Save
Overview
Financials
Filings
Earnings Calls
Short Interest
Ownership
Ratings
Peers
News
Log in
Get Started
Loading latest news…
52w high -13.7%
NPCE
Neuropace, Inc. Common Stock
☁️ News word cloud
Top words across the last 50 articles for this ticker.
neuropace
nasdaq
2023
trading
after
price
last
announced
results
ratings
rating
high
conference
market
analysts
financial
their
medical
epilepsy
nyse
StonvexStonvexStonvexStonvex